17.77 USD
▼-0.07-0.39%
盘后 17.74 -0.17%
2026-09-15
市值
$198.99M
市盈率
—
EPS
-32.19
股息率
—
52 周区间
11.25 – 35.00
成交量
151.94K
Beta
0.56
目标价
44.80
52W 低 11.2552W 高 35.00
价格走势
公司简介
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular ag...